Journals / Uludağ Üniversitesi Tıp Fakültesi Dergisi / 2026 / Cilt: 52

Interictal Serum Uric Acid, Albumin, and Uric Acid-to-Albumin Ratio in Episodic Migraine: A Case–Control Study and Association with Disease Burden

Episodik Migren Hastalarında İnteriktal Serum Ürik Asit, Albümin ve Ürik Asit/Albümin Oranı: Olgu–Kontrol Çalışması ve Hastalık Yükü ile İlişkisi

Deniz Kamacı Şener(Department of Neurology, Bursa City Hospital, Bursa, Türkiye.)0000-0003-3433-6859
Özden Çalışkan Kamışlı(Department of Neurology, Bursa City Hospital, Bursa, Türkiye.)0000-0003-1114-7860
Pages
—
Publication Date
2026-03-16
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further prospective studies are needed to clarify its clinical relevance.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Oxidative stress and systemic inflammation are increasingly recognized as key mechanisms in migraine pathophysiology.
📊
Key Findings & Data:In this retrospective case–control study, 120 patients with episodic migraine and 100 age- and sex-matched healthy controls were included.
💡
Conclusion & Impact:Further prospective studies are needed to clarify its clinical relevance.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Migren · ürik asit · albümin

Abstract

Oxidative stress and systemic inflammation are increasingly recognized as key mechanisms in migraine pathophysiology. Uric acid (UA) and albumin (ALB) contribute to redox and inflammatory balance, and their ratio (UAR) has been proposed as a combined biomarker of these processes. This study evaluated serum UA, ALB, and UAR levels in patients with episodic migraine during the interictal period and examined their associations with clinical features and migraine-related disability. In this retrospective case–control study, 120 patients with episodic migraine and 100 age- and sex-matched healthy controls were included. Serum UA and ALB were measured, and UAR was calculated as UA (mg/dL)/ALB (g/dL). Demographic and laboratory variables were compared between groups. In the migraine group, correlations between biochemical markers and clinical variables, including pain intensity (VAS), migraine-related disability (MIDAS), attack frequency, and aura status, were analyzed. Serum UA and UAR levels were significantly lower in migraine patients than in controls (both p<0.001), whereas ALB levels were similar. UA, ALB, and UAR were not correlated with attack frequency, pain intensity, MIDAS scores, or aura status. Lower UA and UAR levels in episodic migraine may reflect reduced systemic antioxidant capacity. However, the absence of associations with clinical severity suggests that oxidative imbalance may not directly represent migraine burden. UAR may serve as a biochemical indicator of oxidative and inflammatory processes in migraine. Further prospective studies are needed to clarify its clinical relevance.

Özet

Oksidatif stres ve sistemik inflamasyonun migren patofizyolojisinde önemli rol oynadığı giderek daha fazla kabul edilmektedir. Ürik asit (UA) ve albümin (ALB), redoks ve inflamatuvar dengeye katkıda bulunan temel bileşenlerdir. Bu iki parametrenin oranı olan ürik asit/albümin oranı (UAR), bu süreçleri birlikte yansıtan potansiyel bir biyobelirteç olarak önerilmektedir. Bu çalışmada epizodik migren hastalarında interiktal dönemde serum UA, ALB ve UAR düzeyleri değerlendirildi ve bu parametrelerin klinik özellikler ile migrenle ilişkili özürlülükle ilişkisi araştırıldı. Retrospektif olgu–kontrol tasarımındaki çalışmaya 120 epizodik migren hastası ve yaş ve cinsiyet açısından benzer 100 sağlıklı kontrol dahil edildi. Serum UA ve ALB düzeyleri ölçüldü ve UAR, UA (mg/dL) / ALB (g/dL) formülüyle hesaplandı. Gruplar arasında demografik ve laboratuvar verileri karşılaştırıldı. Migren grubunda biyokimyasal belirteçler ile ağrı şiddeti (VAS), MIDAS puanı, atak sıklığı ve aura varlığı arasındaki ilişkiler analiz edildi. Migren hastalarında serum UA ve UAR düzeyleri kontrollere göre anlamlı derecede düşük bulundu (her ikisi için p<0,001), ALB düzeyleri ise benzerdi. UA, ALB ve UAR düzeyleri ile atak sıklığı, ağrı şiddeti, MIDAS puanı veya aura varlığı arasında anlamlı ilişki saptanmadı. Epizodik migrende düşük UA ve UAR düzeyleri azalmış sistemik antioksidan kapasiteyi yansıtabilir. Ancak klinik şiddet ile ilişki saptanmaması, oksidatif dengesizliğin hastalık yükünü doğrudan yansıtmayabileceğini düşündürmektedir. UAR, migrenli hastalarda oksidatif ve inflamatuvar süreçlerin değerlendirilmesinde yararlı bir belirteç olabilir. Klinik öneminin netleştirilmesi için ileriye dönük çalışmalara ihtiyaç vardır.

🔖

Cite This Article

Şener, D. K., Kamışlı, Ö. Ç., *, D. K. Ş. (2026). Interictal Serum Uric Acid, Albumin, and Uric Acid-to-Albumin Ratio in Episodic Migraine: A Case–Control Study and Association with Disease Burden. Uludağ Üniversitesi Tıp Fakültesi Dergisi, Cilt: 52. https://doi.org/10.32708/uutfd.1813892

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (24)

  1. Feigin VL, Vos T, Nichols E, et al. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020;19(3):255-265. doi:10.1016/S1474-4422(19)30411-9.
  2. Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Espada-Rubio S, Agúndez JA. Oxidative stress and migraine. Mol Neurobiol. 2024;61(10):8344-8360. doi:10.1007/s12035-024-04114-7.
  3. Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids. 2008;27(6-7):608-619. doi:10.1080/15257770802138558
  4. Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783-1787. doi:10.1016/j.febslet.2008.04.057
  5. Yalcinkaya D, Karacali K, Ilhan BC, Yarlioglues M. Relation between serum uric acid to albumin ratio and severity of chronic coronary artery disease. Angiology. 2024;75(4):386-393. doi:10.1177/00033197231161902
  6. Altunkaynak Y, Keskek A, Donmezler S, et al. A study of the relationship between serum uric acid levels and pain in patients with migraine. Medicine (Baltimore). 2023;102(5):e32810. doi: 10.1097/MD.0000000000032810.
  7. Yazar T, Yazar HO, Aygün A, Karabacak V, Altunkaynak Y, Kirbaş D. Evaluation of serum uric levels in migraine. Neurol Sci. 2021;42(2):705-709. doi:10.1007/s10072-020-04598-w
  8. Yang Z, Xu P, Geng C, Zhang H. Evaluation of simple antioxidant blood parameters in patients with migraine. Front Neurol. 2022;13:939363. doi:10.3389/fneur.2022.939363
  9. Yasin S, Altunisik E. Decreased serum uric acid level as an indicator of altered oxidative balance in patients with migraine. Cureus. 2022;14(12). doi: 10.7759/cureus.32136.
  10. Şaylık F, Çınar T, Selçuk M, Tanboğa İH. The relationship between uric acid/albumin ratio and carotid intima-media thickness in patients with hypertension. Arq Bras Cardiol. 2023;120:e20220819. doi:10.36660/abc.20220819
  11. Özgür Y, Akın S, Yılmaz NG, Gücün M, Keskin Ö. Uric acid albumin ratio as a predictive marker of short-term mortality in patients with acute kidney injury. Clin Exp Emerg Med. 2021;8(2):82-87. doi:10.15441/ceem.20.024
  12. Taheri M, Nicknafs F, Hesami O, et al. Differential expression of cytokine-coding genes among migraine patients with and without aura and normal subjects. J Mol Neurosci. 2021;71(6):1197-1204. doi:10.1007/s12031-020-01745-y.
  13. Neri M, Frustaci A, Milic M, et al. A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine. Cephalalgia. 2015;35(10):931-937. doi:10.1177/0333102414564888.
  14. Strazzullo P, Puig JG. Uric acid and oxidative stress: relative impact on cardiovascular risk. Nutr Metab Cardiovasc Dis. 2007;17(6):409-414. doi:10.1016/j.numecd.2007.02.011.
  15. Yazar HO, Yazar T, Yildirim T, Keşkek A, Altunkaynak Y. Assessment of serum uric acid levels in patients with restless legs syndrome. Acta Neurol Belg. 2019;119(3):461-466. doi:10.1007/s13760-019-01177-5.
  16. Brody DM, Litvan I, Warner S, et al. Relationship between uric acid levels and progressive supranuclear palsy. Mov Disord. 2016;31(5):663-667. doi:10.1002/mds.26535
  17. 17 Cheng Y-C., Chang Y-T. Serum uric acid and albumin levels in patients with migraine. J Neurol Sci. 2023;455. doi:10.1016/j.jns.2023.121625.
  18. Ersoy A, Yasar H, Mertoglu C, et al. Is ischemia associated with the formation of white matter lesions in migraine? Clin Neurol Neurosurg. 2020;193:105770. doi:10.1016/j.clineuro.2020.105770.
  19. Say B, Badem ND, Ergun U. Serum levels of ischemic modified albumin (IMA) and prolidase in migraine subjects. J Health Sci Med. 2020;3(1):31-35. doi:10.32322/jhsm.638466.
  20. Zhang X-j, Hou A-j, Luan B, Wang C-f, Li J-j. Uric acid to albumin ratio as a novel predictor for coronary slow flow phenomenon in patients with chronic coronary syndrome and non-obstructive coronary arteries. BMC Cardiovasc Disord. 2024;24(1):358. doi:10.1186/s12872-024-04040-5.
  21. Oflar E, Yildiz C, Koyuncu A, et al. Relationship between uric acid albumin ratio and peripheral artery disease complexity. Eur Rev Med Pharmacol Sci. 2023;27(23):11472-11478.
  22. Togha M, Razeghi Jahromi S, Ghorbani Z, Ghaemi A, Rafiee P. An investigation of oxidant/antioxidant balance in patients with migraine: a case-control study. BMC Neurol. 2019;19(1):323. doi:10.1186/s12883-019-1555-4.
  23. Ayata C, Lauritzen M. Spreading depression, spreading depolarizations, and the cerebral vasculature. Physiol Rev. 2015;95(3):953-993. doi:10.1152/physrev.00027.2014.
  24. Charles A, Brennan K. Cortical spreading depression—new insights and persistent questions. Cephalalgia. 2009;29(10):1115-1124. doi:10.1111/j.1468-2982.2009.01983.x.